Omeros (OMER) Profit After Tax (2010 - 2026)
Omeros (OMER) reported Profit After Tax of $56.1 million for Q1 2026, up 249.23% on a YoY basis from $16.1 million in Q1 2025, and down 31.09% sequentially from $81.3 million in Q4 2025.
Omeros (OMER) Profit After Tax (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Profit After Tax data on file, last reported at $56.1 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 249.23% year-over-year to $56.1 million; the trailing twelve-month figure through Mar 2026 stood at $81.1 million (up 143.15% YoY), and the FY2025 full-year result was -$3.4 million, up 98.17% from the prior year.
- Profit After Tax slipped to $56.1 million in Q1 2026, from $81.3 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $183.4 million in Q4 2022 to a low of -$66.2 million in Q4 2023.
- A 5-year average of -$15.8 million and a median of -$37.1 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax surged 274.4% in 2022 and plunged 136.08% in 2023, its largest moves.
- Tracing OMER's Profit After Tax over 5 years: stood at $183.4 million in 2022, then slumped by 136.08% to -$66.2 million in 2023, then grew by 13.6% to -$57.2 million in 2024, then soared by 242.29% to $81.3 million in 2025, then slumped by 31.09% to $56.1 million in 2026.
- Business Quant data shows OMER's Profit After Tax at $56.1 million in Q1 2026, $81.3 million in Q4 2025, and -$30.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Omeros | 707.67 Mn | 707.67 Mn | 9.31 Mn | 56.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.06 Mn |
| Dec 31, 2025 | 81.35 Mn |
| Sep 30, 2025 | -30.92 Mn |
| Jun 30, 2025 | -25.42 Mn |
| Mar 31, 2025 | -37.57 Mn |
| Dec 31, 2024 | -57.17 Mn |
| Sep 30, 2024 | -37.11 Mn |
| Jun 30, 2024 | -56.04 Mn |
| Mar 31, 2024 | -37.18 Mn |
| Dec 31, 2023 | -66.18 Mn |
| Sep 30, 2023 | -51.66 Mn |
| Jun 30, 2023 | -37.29 Mn |
| Mar 31, 2023 | -33.70 Mn |
| Dec 31, 2022 | 183.40 Mn |
| Sep 30, 2022 | -54.79 Mn |
| Jun 30, 2022 | -30.85 Mn |
| Mar 31, 2022 | -33.01 Mn |
| Dec 31, 2021 | -105.16 Mn |
| Sep 30, 2021 | -44.28 Mn |
| Jun 30, 2021 | -28.59 Mn |